Caitong International Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

Caitong International Asset Management’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$126	Sell	94 -1,635	-95%	-$2.61K	﹤0.01%	2120
2026 Q1	$2.06K	Buy	+1,729	New	+$3.03K	﹤0.01%	1235

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Caitong International Asset Management's MIST Position: Q2 2026 in Review

Caitong International Asset Management reduced its Milestone Pharmaceuticals (MIST) stake by 95% in Q2 2026, selling an estimated $2.61K and leaving 94 shares worth $126. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

Caitong International Asset Management first reported a position in MIST in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.06K in Q1 2026. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Caitong International Asset Management held 94 shares of Milestone Pharmaceuticals worth $126 as of Q2 2026.
Caitong International Asset Management sold 1,635 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.61K.
Milestone Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2120 holding.
Caitong International Asset Management first reported a position in Milestone Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
Caitong International Asset Management's Milestone Pharmaceuticals position peaked at $2.06K in Q1 2026.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.